Allison Dorval Verve Therapeutics, Inc. (VERV) insider trading activity

Allison Dorval is Chief Financial Officer of Verve Therapeutics, Inc.. Currently has a direct ownership of 5,380 shares of VERV, which is worth approximately $32,333. The most recent transaction as insider was on Dec 02, 2024, when has been sold 555 shares (Common Stock) at a price of $5.64 per share, resulting in proceeds of $3,130. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.38K

32.51% 3M change

32.51% 12M change

Total Value Held $32,333

Allison Dorval Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 02 2024	SELL Open market or private sale	$3,130 $5.64 p/Share	555 Reduced 9.35%	5,380 Common Stock
Nov 29 2024	BUY Exercise of conversion of derivative security	-	1,875 Added 24.01%	5,935 Common Stock
Nov 29 2023	SELL Open market or private sale	$6,343 $11.45 p/Share	554 Reduced 12.01%	4,060 Common Stock
Nov 29 2023	BUY Exercise of conversion of derivative security	-	1,875 Added 28.9%	4,614 Common Stock
Nov 29 2022	SELL Open market or private sale	$12,243 $22.1 p/Share	554 Reduced 20.22%	2,186 Common Stock
Nov 29 2022	BUY Exercise of conversion of derivative security	-	1,875 Added 40.63%	2,740 Common Stock

Also insider at

VYGR

Voyager Therapeutics, Inc. Healthcare

Chief Financial Officer

PBYI

PUMA BIOTECHNOLOGY, INC. Healthcare

Director

AVTE

Aerovate Therapeutics, Inc. Healthcare

Allison Dorval

Chief Financial Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VERV shares.

Notify only if

Value

Insider Trading

Get notified when an Verve Therapeutics, Inc. insider buys or sells VERV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Verve Therapeutics, Inc.

Track Activities on VERV

Account